Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 mutations characterize a subgroup of muscle-invasive bladder cancers with excellent response to neoadjuvant chemotherapy. Eur Urol. in press. http://dx.doi.org/10.1016/j.eururo.2015.01.014 Journal Article
| Authors: | Van Allen, E. M.; Garraway, L. A.; Rosenberg, J. E. |
| Article Title: | Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 mutations characterize a subgroup of muscle-invasive bladder cancers with excellent response to neoadjuvant chemotherapy. Eur Urol. in press. http://dx.doi.org/10.1016/j.eururo.2015.01.014 |
| Keywords: | treatment response; gene mutation; cisplatin; adjuvant therapy; cancer adjuvant therapy; letter; carboplatin; epidermal growth factor receptor 2; adjuvant chemotherapy; muscle invasive bladder cancer; human; priority journal |
| Journal Title: | European Urology |
| Volume: | 68 |
| Issue: | 2 |
| ISSN: | 0302-2838 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2015-08-01 |
| Start Page: | e31 |
| End Page: | e32 |
| Language: | English |
| DOI: | 10.1016/j.eururo.2015.02.044 |
| PROVIDER: | scopus |
| PUBMED: | 25770487 |
| DOI/URL: | |
| Notes: | Export Date: 2 September 2015 -- Source: Scopus |
